BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 10097034)

  • 1. Role of GLP-1 in meal-taking.
    Hellström PM; Näslund E
    Appetite; 1999 Apr; 32(2):276. PubMed ID: 10097034
    [No Abstract]   [Full Text] [Related]  

  • 2. Glucagon-like peptide-1, satiety and appetite control.
    Blundell JE; Naslund E
    Br J Nutr; 1999 Apr; 81(4):259-60. PubMed ID: 10999011
    [No Abstract]   [Full Text] [Related]  

  • 3. Glucagon-like peptide-1. Gastrointestinal function and possible mechanism of action.
    Wettergren A
    Dan Med Bull; 2001 Feb; 48(1):19-28. PubMed ID: 11258148
    [No Abstract]   [Full Text] [Related]  

  • 4. Glucagon-like peptide 1 (GLP-1) and eating.
    Gutzwiller JP; Degen L; Heuss L; Beglinger C
    Physiol Behav; 2004 Aug; 82(1):17-9. PubMed ID: 15234584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Glucagon-like peptide 1--a new physiologic mediator of satiety?].
    Gallwitz B; Schmidt WE
    Z Gastroenterol; 1996 Nov; 34(11):775-7. PubMed ID: 9045540
    [No Abstract]   [Full Text] [Related]  

  • 6. No effect of glucagon-like peptide-1 on short-term satiety and energy intake in man.
    Long SJ; Sutton JA; Amaee WB; Giouvanoudi A; Spyrou NM; Rogers PJ; Morgan LM
    Br J Nutr; 1999 Apr; 81(4):273-9. PubMed ID: 10999014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is there appetite after GLP-1 and PACAP?
    Christophe J
    Ann N Y Acad Sci; 1998 Dec; 865():323-35. PubMed ID: 9928026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucagon-like peptide 1 as a regulator of food intake and body weight: therapeutic perspectives.
    Meier JJ; Gallwitz B; Schmidt WE; Nauck MA
    Eur J Pharmacol; 2002 Apr; 440(2-3):269-79. PubMed ID: 12007541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastrointestinal satiety signals III. Glucagon-like peptide 1, oxyntomodulin, peptide YY, and pancreatic polypeptide.
    Stanley S; Wynne K; Bloom S
    Am J Physiol Gastrointest Liver Physiol; 2004 May; 286(5):G693-7. PubMed ID: 15068960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hindbrain contributions to anorexia.
    Rinaman L
    Am J Physiol Regul Integr Comp Physiol; 2004 Nov; 287(5):R1035-6. PubMed ID: 15475502
    [No Abstract]   [Full Text] [Related]  

  • 11. The potential role of glucagon-like peptide 1 in diabetes.
    Meier JJ; Nauck MA
    Curr Opin Investig Drugs; 2004 Apr; 5(4):402-10. PubMed ID: 15134281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucagon-like peptide 1(GLP-1) in biology and pathology.
    Meier JJ; Nauck MA
    Diabetes Metab Res Rev; 2005; 21(2):91-117. PubMed ID: 15759282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucagon-like peptide-1: a potent regulator of food intake in humans.
    Gutzwiller JP; Göke B; Drewe J; Hildebrand P; Ketterer S; Handschin D; Winterhalder R; Conen D; Beglinger C
    Gut; 1999 Jan; 44(1):81-6. PubMed ID: 9862830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac metabolism as a target for the treatment of heart failure.
    Taegtmeyer H
    Circulation; 2004 Aug; 110(8):894-6. PubMed ID: 15326079
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical endocrinology and metabolism. Glucagon-like peptide-1 and glucagon-like peptide-2.
    Baggio LL; Drucker DJ
    Best Pract Res Clin Endocrinol Metab; 2004 Dec; 18(4):531-54. PubMed ID: 15533774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central glucagon-like peptide-I in the control of feeding.
    Gunn I; O'Shea D; Turton MD; Beak SA; Bloom SR
    Biochem Soc Trans; 1996 May; 24(2):581-4. PubMed ID: 8736807
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of glucagon-like peptide-1 (GLP-1) on glucose homeostasis and food intake.
    Balkan B
    Appetite; 2000 Dec; 35(3):269-70. PubMed ID: 11073709
    [No Abstract]   [Full Text] [Related]  

  • 18. The role of GLP-1 in the life and death of pancreatic beta cells.
    Perfetti R; Hui H
    Horm Metab Res; 2004; 36(11-12):804-10. PubMed ID: 15655712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of intracerebroventricularly injected glucagon-like peptide-1 on cardiovascular parameters; role of central cholinergic system and vasopressin.
    Isbil-Buyukcoskun N; Gulec G
    Regul Pept; 2004 Apr; 118(1-2):33-8. PubMed ID: 14759554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Glucagon and GLP (glucagon-like peptide)].
    Matsuyama T
    Nihon Rinsho; 2002 Jul; 60 Suppl 7():246-51. PubMed ID: 12238055
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.